SorafenibNeutropenia and off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1927卷 / 1期

关键词：

D O I：

10.1007/s40278-022-25218-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：482 / 482

相关论文

共 50 条

[1] RituximabPneumocystosis and off label use: case report
Reactions Weekly, 2022, 1920 (1) : 419 - 419
[2] MethylprednisoloneAspergillosis and off label use: case report
Reactions Weekly, 2023, 1954 (1) : 281 - 281
[3] TocilizumabTransaminitis and off label use: case report
Reactions Weekly, 2023, 1953 (1) : 365 - 365
[4] EverolimusPneumonitis and off label use: case report
Reactions Weekly, 2019, 1750 (1) : 122 - 122
[5] TemozolomideNeutropenia and off label use: case report
Reactions Weekly, 2020, 1789 (1) : 252 - 252
[6] CotrimoxazoleHyperkalaemia and off label use: case report
Reactions Weekly, 2022, 1909 (1) : 194 - 194
[7] TeriparatideHypercalciuria and off label use: case report
Reactions Weekly, 2022, 1919 (1) : 561 - 561
[8] DexamethasoneOsteonecrosis and off label use: case report
Reactions Weekly, 2022, 1922 (1) : 216 - 216
[9] RituximabHypogammaglobulinaemia and off label use: case report
Reactions Weekly, 2023, 1948 (1) : 381 - 381
[10] Calcitriol/ketoconazoleHypercalcaemia and off label use: case report
Reactions Weekly, 2021, 1838 (1) : 123 - 123

← 1 2 3 4 5 →